BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Targets/VDR/Compounds

Compounds That Target VDR

vitamin D receptor · 129 compounds in BiohacksAI corpus

VDR (vitamin D receptor) is a biological target with 129 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into VDR modulation for therapeutic and biohacking applications.

View VDR target page →UniProt: BAH02291 ↗
Most Studied Compounds for VDR
1
Centella Asiatica
499+
studies
2
Calcitriol
300+
studies
3
Lithocholic Acid
300+
studies
4
Oxyphenbutazone
300+
studies
5
Ethidium Bromide
300+
studies
6
Dinitrochlorobenzene
300+
studies
7
Idazoxan
300+
studies
8
Menadione
300+
studies
9
Sodium Dodecyl Sulfate
300+
studies
10
Wortmannin
300+
studies
All 54 Compounds — Ranked by Evidence
1
Trichostatin
5.45
confidence
2
Calcitriol
300+
studies
4.65
confidence
3
Lithocholic Acid
300+
studies
2.56
confidence
4
E Guggulsterone
2.40
confidence
5
Lithoglycocholate
2.08
confidence
6
Cholecalciferol
299+
studies
1.95
confidence
7
Oxyphenbutazone
300+
studies
1.61
confidence
8
Disulfiram
297+
studies
1.61
confidence
9
Ethidium Bromide
300+
studies
1.61
confidence
10
Dactinomycin
297+
studies
1.39
confidence
11
Nisoldipinedrugage
1.39
confidence
12
Dinitrochlorobenzene
300+
studies
1.10
confidence
13
Fccp
76+
studies
1.10
confidence
14
Idazoxan
300+
studies
1.10
confidence
15
Juglone
279+
studies
1.10
confidence
16
Menadione
300+
studies
1.10
confidence
17
Podofilox
14+
studies
1.10
confidence
18
Sodium Dodecyl Sulfate
300+
studies
1.10
confidence
19
Wortmannin
300+
studies
1.10
confidence
20
Apigenin
300+
studies
1.10
confidence
21
Arachidonic Acid
245+
studies
1.10
confidence
22
Dha
300+
studies
1.10
confidence
23
Plumbagin
300+
studies
1.10
confidence
24
Alpha Linolenic Acid
300+
studies
1.10
confidence
25
Smilax Glabra
1.00
confidence
26
Centella Asiatica
499+
studies
1.00
confidence
27
Bombyx Mori
1.00
confidence
28
Anemarrhena Asphodeloides
1.00
confidence
29
Edaravone
298+
studies
0.69
confidence
30
Catechins
51+
studies
0.69
confidence
31
Chrysinflavonoids
0.69
confidence
32
Dim
56+
studies
0.69
confidence
33
Amethopterin
289+
studies
0.69
confidence
34
Amoxapine
259+
studies
0.69
confidence
35
Aurintricarboxylic Acid
184+
studies
0.69
confidence
36
Bromocriptine
299+
studies
0.69
confidence
37
C75
49+
studies
0.69
confidence
38
Calcifediol
300+
studies
0.69
confidence
39
Calcimycin
216+
studies
0.69
confidence
40
Candesartan Cilexetil
300+
studies
0.69
confidence
41
Carbaryl
300+
studies
0.69
confidence
42
Carnosic Acid
300+
studies
0.69
confidence
43
Cefaclor
299+
studies
0.69
confidence
44
Cefpirome
300+
studies
0.69
confidence
45
Colchicineheterocyclic
0.69
confidence
46
Cycloheximide
300+
studies
0.69
confidence
47
Emetine
298+
studies
0.69
confidence
48
Epinephrine
299+
studies
0.69
confidence
49
Estramustine
300+
studies
0.69
confidence
50
Ethoxyquin
180+
studies
0.69
confidence
51
D609
49+
studies
0.69
confidence
52
Daunorubicin
298+
studies
0.69
confidence
53
Diallyl Trisulfide
246+
studies
0.69
confidence
54
Diamide
300+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for VDR (vitamin D receptor). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: VDR target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.